china.org.cn
Bayer's Commitment to China
Bayer reaffirms its commitment to the Chinese market with significant investments and collaborations.
English
China
TechnologyHealthHealthcareInvestmentGrowthCollaboration
BayerChina International Import Expo (Ciie)
Nelson Ambrogio
- What significant investment is Bayer making in China?
- A key aspect of Bayer's commitment is a multi-million dollar supply center in Beijing, which aims to begin local production of injectors within three to five years.
- What is Bayer's overall commitment to the Chinese market?
- Bayer, a life science company, has reaffirmed its commitment to the Chinese market, highlighting its significant investments and partnerships in the country.
- What key products or technologies has Bayer introduced in China?
- Bayer's radiology business has introduced over 100 innovative technologies and launched eight new products in China in the past seven years, including the MEDRAD Centargo CT Injection System.
- How is Bayer collaborating with Chinese institutions and scientists?
- Bayer is collaborating with Chinese institutions and scientists, focusing on data generation and developing solutions specific to the Chinese population. They are also exploring commercialization opportunities for Chinese institutional research.
- What are the main points highlighted by Nelson Ambrogio regarding the company's strategy in China?
- Nelson Ambrogio, head of Bayer's radiology business, emphasized the growth of the Chinese market and Bayer's continued investments in research, development, and local production within China.